Moderna's RSV vaccine shown to provide strong protection against serious cases in adults 50 and older

Medical Xpress - latest medical and health news stories · 3h ago

A single dose of Moderna's mResvia RSV vaccine was 60.3% protective against documented respiratory syncytial virus (RSV) infections, 60.2% against RSV-associated emergency department or urgent care encounters and 81.8% against RSV-associated hospitalizations in a population of older U.S. veterans, according to a recent study in JAMA Network Open.

Read original article on Medical Xpress - latest medical and health news stories →

Moderna's RSV vaccine shown to provide strong protection against serious cases in adults 50 and older

Related news